Search details
1.
When symptoms are more than reflux.
Rev Esp Enferm Dig
; 2024 May 22.
Article
in English
| MEDLINE | ID: mdl-38775393
2.
Review document of the Spanish Association of Neurogastroenterology and Motility on the management of opioid-induced constipation.
Rev Esp Enferm Dig
; 2024 Feb 02.
Article
in English
| MEDLINE | ID: mdl-38305669
3.
Asociación Española de Neurogastroenterología y Motilidad (ASENEM) updated review on the management of functional abdominal pain. / Documento de puesta al día de la Asociación Española de Neurogastroenterología y Motilidad (ASENEM) sobre el manejo del dolor abdominal funcional.
Gastroenterol Hepatol
; 2024 Apr 26.
Article
in English, Spanish
| MEDLINE | ID: mdl-38677507
4.
Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS).
J Allergy Clin Immunol
; 149(2): 659-670, 2022 02.
Article
in English
| MEDLINE | ID: mdl-34242635
5.
Practical approach to irritable bowel syndrome-diarrhea beyond low-FODMAP diet.
Rev Esp Enferm Dig
; 114(8): 481-488, 2022 08.
Article
in English
| MEDLINE | ID: mdl-35694883
6.
Irritable bowel syndrome and basal serum tryptase: correlation between subtype, severity, and comorbidities. A pilot study.
Rev Esp Enferm Dig
; 114(1): 22-27, 2022 Jan.
Article
in English
| MEDLINE | ID: mdl-33562988
7.
Budesonide Orodispersible Tablets Maintain Remission in a Randomized, Placebo-Controlled Trial of Patients With Eosinophilic Esophagitis.
Gastroenterology
; 159(5): 1672-1685.e5, 2020 11.
Article
in English
| MEDLINE | ID: mdl-32721437
8.
Diagnostic and therapeutic challenges in the management of obstructive defecation.
Rev Esp Enferm Dig
; 113(8): 619, 2021 08.
Article
in English
| MEDLINE | ID: mdl-33397119
9.
Risk of COVID-19 transmission in esophageal, anorectal manometry and 24-hour impedance-pH monitoring.
Rev Esp Enferm Dig
; 113(5): 332-338, 2021 05.
Article
in English
| MEDLINE | ID: mdl-33733801
10.
Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled Trial.
Gastroenterology
; 157(1): 74-86.e15, 2019 07.
Article
in English
| MEDLINE | ID: mdl-30922997
11.
Obstructed defecation syndrome: a diagnostic and therapeutic challenge.
Rev Esp Enferm Dig
; 112(6): 477-482, 2020 Jun.
Article
in English
| MEDLINE | ID: mdl-32450707
12.
High-resolution and high-definition anorectal manometry: rediscovering anorectal function.
Rev Esp Enferm Dig
; 110(12): 794-805, 2018 Dec.
Article
in English
| MEDLINE | ID: mdl-30345781
13.
Esophageal motor disorders are frequent during pre and post lung transplantation. Can they influence lung rejection?
Rev Esp Enferm Dig
; 110(6): 344-351, 2018 Jun.
Article
in English
| MEDLINE | ID: mdl-29421915
14.
Consensus document on exclusion diets in irritable bowel syndrome (IBS).
Rev Esp Enferm Dig
; 110(12): 806-824, 2018 Dec.
Article
in English
| MEDLINE | ID: mdl-30421956
15.
Practical aspects of high resolution esophageal manometry.
Rev Esp Enferm Dig
; 109(2): 91-105, 2017 Feb.
Article
in English
| MEDLINE | ID: mdl-27990836
16.
Questionnaires for the diagnosis of gastroesophageal reflux disease: are they really useful?
Rev Esp Enferm Dig
; 108(4): 171-3, 2016 Apr.
Article
in English
| MEDLINE | ID: mdl-26938193
17.
How useful is esophageal high resolution manometry in diagnosing gastroesophageal junction disruption: causes affecting this disruption and its relationship with manometric alterations and gastroesophageal reflux.
Rev Esp Enferm Dig
; 106(1): 22-9, 2014 Jan.
Article
in English
| MEDLINE | ID: mdl-24689712
18.
Transcultural adaptation and validation of the "Adult Eosinophilic Esophagitis Quality of Life Questionnaire" into Spanish.
Rev Esp Enferm Dig
; 106(6): 386-94, 2014 Jun.
Article
in English
| MEDLINE | ID: mdl-25361449
19.
Candida colitis: an endoscopic diagnosis.
Gastrointest Endosc
; 88(4): 780, 2018 10.
Article
in English
| MEDLINE | ID: mdl-29908173
20.
Budesonide orodispersible tablets for induction of remission in patients with active eosinophilic oesophagitis: A 6-week open-label trial of the EOS-2 Programme.
United European Gastroenterol J
; 10(3): 330-343, 2022 04.
Article
in English
| MEDLINE | ID: mdl-35412032